Linked Life Data

15773907

Source:http://linkedlifedata.com/resource/pubmed/id/15773907

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15773907rdf:typepubmed:Citationlld:pubmed
pubmed-article:15773907lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C0600388lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C1621980lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:15773907lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:15773907pubmed:issue1lld:pubmed
pubmed-article:15773907pubmed:dateCreated2005-3-18lld:pubmed
pubmed-article:15773907pubmed:abstractTextNeurotrophins play important roles in the response of adult neurons to injury. The intracellular signaling mechanisms used by neurotrophins to regulate survival and axon growth in the mature CNS in vivo are not well understood. The goal of this study was to define the role of the extracellular signal-regulated kinases 1/2 (Erk1/2) pathway in the survival and axon regeneration of adult rat retinal ganglion cells (RGCs), a prototypical central neuron population. We used recombinant adeno-associated virus (AAV) to selectively transduce RGCs with genes encoding constitutively active or wild-type mitogen-activated protein kinase kinase 1 (MEK1), the upstream activator of Erk1/2. In combination with anterograde and retrograde tracing techniques, we monitored neuronal survival and axon regeneration in vivo. MEK1 gene delivery led to robust and selective transgene expression in multiple RGC compartments including cell bodies, dendrites, axons and targets in the brain. Furthermore, MEK1 activation induced in vivo phosphorylation of Erk1/2 in RGC bodies and axons. Quantitative analysis of cell survival demonstrated that Erk1/2 activation promoted robust RGC neuroprotection after optic nerve injury. In contrast, stimulation of the Erk1/2 pathway was not sufficient to induce RGC axon growth beyond the lesion site. We conclude that the Erk1/2 pathway plays a key role in the survival of axotomized mammalian RGCs in vivo, and that activation of other signaling components is required for axon regeneration in the growth inhibitory CNS environment.lld:pubmed
pubmed-article:15773907pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:languageenglld:pubmed
pubmed-article:15773907pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:citationSubsetIMlld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15773907pubmed:statusMEDLINElld:pubmed
pubmed-article:15773907pubmed:monthAprlld:pubmed
pubmed-article:15773907pubmed:issn0022-3042lld:pubmed
pubmed-article:15773907pubmed:authorpubmed-author:HauswirthWill...lld:pubmed
pubmed-article:15773907pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:15773907pubmed:authorpubmed-author:PernetVincent...lld:pubmed
pubmed-article:15773907pubmed:issnTypePrintlld:pubmed
pubmed-article:15773907pubmed:volume93lld:pubmed
pubmed-article:15773907pubmed:ownerNLMlld:pubmed
pubmed-article:15773907pubmed:authorsCompleteYlld:pubmed
pubmed-article:15773907pubmed:pagination72-83lld:pubmed
pubmed-article:15773907pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:meshHeadingpubmed-meshheading:15773907...lld:pubmed
pubmed-article:15773907pubmed:year2005lld:pubmed
pubmed-article:15773907pubmed:articleTitleExtracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo.lld:pubmed
pubmed-article:15773907pubmed:affiliationDepartment of Pathology and Cell Biology, Université de Montréal, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:15773907pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15773907pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15773907pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15773907pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15773907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15773907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15773907lld:pubmed